These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28750644)

  • 1. A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors.
    Zhang N; Chen R; Hua K; Zhang Y
    J Ovarian Res; 2017 Jul; 10(1):52. PubMed ID: 28750644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Update on malignant nonepithelial ovarian tumours].
    Bats AS; Larousserie F; Le Frère Belda MA; Metzger U; Lécuru F
    Gynecol Obstet Fertil; 2009; 37(7-8):627-32. PubMed ID: 19574079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
    Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
    J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center.
    Mikuš M; Benco N; Matak L; Planinić P; Ćorić M; Lovrić H; Radošević V; Puževski T; Bajt M; Vujić G
    Arch Gynecol Obstet; 2020 May; 301(5):1227-1233. PubMed ID: 32253553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility sparing surgery in malignant ovarian Germ cell tumor (MOGCT): 15 years experiences.
    Zamani N; Rezaei Poor M; Ghasemian Dizajmehr S; Alizadeh S; Modares Gilani M
    BMC Womens Health; 2021 Aug; 21(1):282. PubMed ID: 34348686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes.
    Shim SH; Kim DY; Lee SW; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2013 Feb; 23(2):249-55. PubMed ID: 23318909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fertility-sparing surgery on sexuality and global quality of life in women with malignant ovarian germ cell and sex cord stromal tumors: an analysis of the CORSETT database of the AGO study group.
    Hasenburg A; Plett H; Krämer B; Braicu E; Czogalla B; Bossart M; Singer S; Mayr D; Staebler A; du Bois A; Kommoss S; Link T; Burges A; Heitz F; Keul J; Trillsch F; Harter P; Wimberger P; Buderath P; Klar M
    Arch Gynecol Obstet; 2021 Dec; 304(6):1541-1549. PubMed ID: 34287678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.
    Weinberg LE; Lurain JR; Singh DK; Schink JC
    Gynecol Oncol; 2011 May; 121(2):285-9. PubMed ID: 21256579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database.
    Bossart M; Plett H; Krämer B; Braicu E; Czogalla B; Klar M; Singer S; Mayr D; Staebler A; du Bois A; Kommoss S; Link T; Burges A; Heitz F; Grube M; Trillsch F; Harter P; Wimberger P; Buderath P; Hasenburg A
    Arch Gynecol Obstet; 2023 Apr; 307(4):1155-1162. PubMed ID: 36127525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant ovarian germ cell tumors: a single-institution experience.
    Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
    Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive function assessment after surgery plus chemotherapy for germ cell ovarian tumors (MOGCT): novel clues deriving from the field of fertility preservation.
    Ottolina J; Mangili G; Sigismondi C; Vanni VS; Viganò P; Candiani M
    Gynecol Endocrinol; 2014 Nov; 30(11):778-80. PubMed ID: 25034573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours.
    Gadducci A; Lanfredini N; Tana R
    Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility sparing surgery for ovarian sex cord stromal tumors: a nine case series.
    Ghalleb M; Bouzaiene H; Sghaier S; Bouaziz H; Hechiche M; Hassouna JB; Rahal K
    Pan Afr Med J; 2018; 31():221. PubMed ID: 31447979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary.
    Talukdar S; Kumar S; Bhatla N; Mathur S; Thulkar S; Kumar L
    Gynecol Oncol; 2014 Jan; 132(1):28-32. PubMed ID: 24145115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian masses in children and adolescents - an analysis of 521 clinical cases.
    Zhang M; Jiang W; Li G; Xu C
    J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):e73-7. PubMed ID: 24157281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".
    Solheim O; Tropé CG; Rokkones E; Kærn J; Paulsen T; Salvesen HB; Hagen B; Vereide AB; Fosså SD
    Gynecol Oncol; 2015 Feb; 136(2):224-9. PubMed ID: 25511159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers.
    Gomes TA; Campos EA; Yoshida A; Sarian LO; Andrade LALA; Derchain SF
    Rev Bras Ginecol Obstet; 2020 Sep; 42(9):555-561. PubMed ID: 32992358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative surgery in patients with malignant ovarian germ cell tumours.
    Al-Sayed MM; El-Sayed AA; El-Barbary TM; Hamad O
    J Egypt Soc Parasitol; 2011 Dec; 41(3):737-44. PubMed ID: 22435165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.